Clinical Trials Logo

Hemorrhage clinical trials

View clinical trials related to Hemorrhage.

Filter by:

NCT ID: NCT01914419 Completed - Clinical trials for Postpartum Hemorrhage

Oxytocin Via Intramuscular Injection and Intravenous Bolus or Infusion for Prevention of Postpartum Hemorrhage

Start date: April 2014
Phase: N/A
Study type: Interventional

The study will evaluate whether prophylactic oxytocin administered in the third stage of labor via intravenous (IV) infusion or IV bolus reduces the rate of postpartum hemorrhage compared to intramuscular (IM) injection.

NCT ID: NCT01908738 Completed - Clinical trials for Abnormal Uterine Bleeding

Effectiveness of Paracervical Block Versus Lidocaine Spray During Endometrial Biopsy

Start date: September 2013
Phase: N/A
Study type: Interventional

The purpose of this study to determine effectiveness of paracervical block, lidocaine spray and only oral analgesic drugs for pain relief during endometrial biopsy.

NCT ID: NCT01902459 Completed - Hemorrhage Clinical Trials

EVARRESTâ„¢ Fibrin Sealant Patch Post-Market Study

EVARREST
Start date: July 1, 2013
Phase: Phase 4
Study type: Interventional

The objective of this study is to evaluate the clinical utility of EVARRESTâ„¢ Fibrin Sealant Patch (Fibrin Pad) as an adjunct to hemostasis in soft tissue bleeding during intra-abdominal (stomach area), retroperitoneal (hip and stomach area), pelvic (hip area) and non-cardiac thoracic (chest area) surgery.

NCT ID: NCT01899651 Completed - Clinical trials for Intraventricular Brain Hemorrhage

Detection and Quantification of Neonatal Intraventricular Hemorrhage

DQNIH
Start date: May 2014
Phase: N/A
Study type: Observational

Dense array EEG and EIT (electrical impedence tomography) are new technologies that can add to information needed to diagnose neurological problems in infants - both preterm and term. The investigators propose a method to test these technologies in the preterm population to determine its safety and ease of use. The investigators will test on preterm infants of 30-34 weeks gestation, starting first with the older infants (32-34 weeks) then moving down to the smaller population (30-32 weeks). In both groups the investigators will start with a short time period and gradually extend the time as safety is established. All studies will be conducted at Shands Teaching Hospital at the University of Florida.

NCT ID: NCT01897220 Completed - Clinical trials for Perioperative Period

Perioperative Ischemia Versus Perioperative Bleeding During Non-cardiac Surgery in Cardiac Patients

PRAGUE-14
Start date: December 2011
Phase:
Study type: Observational [Patient Registry]

The aim of the study is to analyze the present use of antithrombotic therapy on a large cohort of consecutive cardiacs undergoing non-cardiac surgery. If even and for how long the medication was discontinued, if any other antithrombotic therapy was used in the perioperative period and prevalence of perioperative complications - especially ischemic or bleeding. These complications will be correlated with the pattern of antithrombotic therapy administration. Working hypothesis is to obtain a large database of unselected cohort of consecutive patients for mapping of this practically important, but in the evidence-based medicine, still neglected problem.

NCT ID: NCT01895218 Completed - Clinical trials for Postpartum Haemorrhage

Treatment of Women After Postpartum Haemorrhage

PP-01
Start date: June 2013
Phase: Phase 3
Study type: Interventional

The primary purpose of this study is to compare the efficacy of IV high single dose infusion of iron isomaltoside 1000 to standard medical care in women with PPH evaluated as physical fatigue.

NCT ID: NCT01895205 Completed - Clinical trials for Severe Postpartum Haemorrhage

Treatment of Women After Severe Postpartum Haemorrhage

PP-02
Start date: June 2013
Phase: Phase 3
Study type: Interventional

The primary purpose of this study is to get explorative information about IV high single dose infusion of iron isomaltoside 1000 compared to RBC transfusion in the treatment of severe PP-IDA evaluated as physical fatigue

NCT ID: NCT01895101 Completed - Cardiac Surgery Clinical Trials

The Effect on Blood Loss of Topical and Intravenous Tranexamic Acid in Cardiac Surgery Patients

Start date: October 2013
Phase: Phase 4
Study type: Interventional

It remains still unclear whether topical tranexamic acid has an added value besides the administration of intravenously tranexamic acid. We hypothesize that the addition of topical tranexamic acid, besides intravenous administration of tranexamic acid, results in a 25% reduction of post-operative blood loss after cardiac surgery. The aim of this study is to determine whether the application of topical tranexamic acid reduces the 12 hours postoperative blood loss by 25% in patient scheduled for cardiac surgery on cardiopulmonary bypass, whereby intravenous tranexamic acid is administrated. Just before sternal closure, 250 subjects receives pericardial lavage with 2 gr tranexamic acid in 200 ml normothermic saline solution (NaCl 0.9%), 250 subjects receives pericardial lavage with 200 ml normothermic saline solution without TA and 250 subjects (control group) receives no pericardial lavage. The main study parameter is 12 hours post-operative blood loss and is assessed by 12 hours post-operative chest tube production.

NCT ID: NCT01893190 Completed - Clinical trials for Ruptured Cerebral Aneurysm

Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage

NEWTON
Start date: September 2013
Phase: Phase 1/Phase 2
Study type: Interventional

Phase 1/2a Multicenter, Controlled, Randomized, Open Label, Dose Escalation, Safety, Tolerability, and Pharmacokinetic Study Comparing EG-1962 and Nimodipine in Patients with Aneurysmal Subarachnoid Hemorrhage

NCT ID: NCT01891838 Completed - Surgery Clinical Trials

Mode of Ventilation and Bleeding During Transsphenoidal Surgery

Vent-Hyp
Start date: June 2013
Phase: N/A
Study type: Interventional

The risk of bleeding is important during transsphenoidal surgery. This study aims to find if the ventilation mode, controlled pressure and controlled volume, modifies the risk of bleeding.